Copyright
©The Author(s) 2020.
World J Gastrointest Endosc. Nov 16, 2020; 12(11): 408-450
Published online Nov 16, 2020. doi: 10.4253/wjge.v12.i11.408
Published online Nov 16, 2020. doi: 10.4253/wjge.v12.i11.408
Ref. | Year | Country | Study design | n | Polyp morphology | Procedure | Medication | Relative risk |
Zhang et al[48] | 2018 | China | Prospective | 203 | Polyp size 6-9 mm | EMR | No medications | No incidence of PPB. Incidence of immediate/intraprocedural bleeding 1.7% |
So et al[50] | 2019 | South Korea | Retrospective | 798 | Mean polyp size 34 mm | EMR | No medications | Incidence of PPB 6.3% |
Kim et al[49] | 2019 | South Korea | Retrospective | 717 | Polyp size ≥ 6 mm to < 20 mm | EMR | No medications | Incidence of PPB 1.7% |
- Citation: Chan A, Philpott H, Lim AH, Au M, Tee D, Harding D, Chinnaratha MA, George B, Singh R. Anticoagulation and antiplatelet management in gastrointestinal endoscopy: A review of current evidence. World J Gastrointest Endosc 2020; 12(11): 408-450
- URL: https://www.wjgnet.com/1948-5190/full/v12/i11/408.htm
- DOI: https://dx.doi.org/10.4253/wjge.v12.i11.408